tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market
Advertisement

Urogen Pharma (URGN) Technical Analysis

Compare
631 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is -0.26, suggesting Urogen Pharma is a Sell.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 17.55, while Urogen Pharma’s (URGN) share price is $18.14, making it a Buy.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 17.61, while Urogen Pharma’s (URGN) share price is $18.14, making it a Buy.

Urogen Pharma (URGN) Pivot Points

Oct 22, 2025, 08:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.27
15.82
16.91
17.46
18.55
19.10
20.19
Fibonacci
15.82
16.44
16.83
17.46
18.08
18.47
19.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Oct 22, 2025, 08:55 PM
Period
Simple
Exponential
MA5
17.46Buy
17.58Buy
MA10
17.12Buy
17.40Buy
MA20
17.50Buy
17.55Buy
MA50
18.50Sell
17.61Buy
MA100
16.22Buy
16.37Buy
MA200
13.15Buy
14.16Buy
Urogen Pharma’s (URGN) 10-Day exponential moving average is 17.40, while Urogen Pharma’s (URGN) share price is $18.14, making it a Buy.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 16.37, while Urogen Pharma’s (URGN) share price is $18.14, making it a Buy.
Urogen Pharma’s (URGN) stock price is $18.14 and Urogen Pharma’s (URGN) 50-day simple moving average is 18.50, creating a Sell signal.
Urogen Pharma’s (URGN) stock price is $18.14 and Urogen Pharma’s (URGN) 100-day simple moving average is 16.22, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $18.14 and Urogen Pharma’s (URGN) 200-day simple moving average is 13.15, creating a Buy signal.

Urogen Pharma (URGN) Technical Indicators

Oct 22, 2025, 08:55 PM
Name
Value
Implied Action
RSI (14)
53.54
Neutral
STOCH (9,6)
85.47
Sell
STOCHRSI (14)
56.78
Neutral
MACD (12,26)
-0.26
Sell
ADX (14)
16.85
Buy
Williams %R
-4.60
Sell
CCI (14)
53.53
Neutral
ATR (14)
1.00
-
Ultimate Oscillator
61.47
Neutral
ROC
1.80
Buy
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 53.54, creating a Neutral signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 16.85, creating a Buy signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is 53.53, creating a Neutral signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is 1.80, creating a Buy signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Buy.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 53.54, which suggests URGN is a Neutral.
      What is URGN’s MACD?
      URGN’s MACD is -0.26, which suggests URGN is a Sell.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 17.46, which suggests URGN is a Buy.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 17.50, which suggests URGN is a Buy.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 18.50, which suggests URGN is a Sell.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 13.15, which suggests URGN is a Buy.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -4.60, which suggests URGN is a Sell.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is 53.53, which suggests URGN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis